Clinical Trial Update: Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia [Phase 2]

View source ↗

Summary

Phase II study of lenalidomide combined with eltrombopag in adults with symptomatic anemia due to myelodysplastic syndromes completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Myelodysplastic Syndrome

Drugs mentioned

• Eltrombopag (eltrombopag)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Adult Myelodysplastic Syndrome, Anemia | Phase 2 | Status: COMPLETED | Results posted: 2023-07-27